The flexor retinaculum is the only structure that is divided in the surgical treatment of carpal tunnel syndrome. It is important to protect all other structures during the procedure as damaging them could result in further injury or disability. The purpose of dividing the flexor retinaculum is to decompress the median nerve.

Understanding Carpal Tunnel Syndrome

Carpal tunnel syndrome is a condition that occurs when the median nerve in the carpal tunnel is compressed. Patients with this condition typically experience pain or pins and needles in their thumb, index, and middle fingers. In some cases, the symptoms may even ascend proximally. Patients often shake their hand to obtain relief, especially at night.

During an examination, doctors may observe weakness of thumb abduction and wasting of the thenar eminence (not the hypothenar). Tapping on the affected area may cause paraesthesia, which is known as Tinel’s sign. Flexion of the wrist may also cause symptoms, which is known as Phalen’s sign.

Carpal tunnel syndrome can be caused by a variety of factors, including idiopathic reasons, pregnancy, oedema (such as heart failure), lunate fracture, and rheumatoid arthritis. Electrophysiology tests may show prolongation of the action potential in both motor and sensory nerves.

Treatment for carpal tunnel syndrome may include a 6-week trial of conservative treatments, such as corticosteroid injections and wrist splints at night. If symptoms persist or are severe, surgical decompression (flexor retinaculum division) may be necessary.

The observed symptoms suggest the presence of a spinal disc prolapse, which is causing sensory loss in the posterolateral aspect of the leg and lateral aspect of the foot, weakness in plantar flexion of the foot, reduced ankle reflex, and a positive sciatic nerve stretch test.

Understanding Prolapsed Disc and its Features

A prolapsed lumbar disc is a common cause of lower back pain that can lead to neurological deficits. It is characterized by clear dermatomal leg pain, which is usually worse than the back pain. The pain is often aggravated when sitting. The features of the prolapsed disc depend on the site of compression. For instance, L3 nerve root compression can cause sensory loss over the anterior thigh, weak quadriceps, reduced knee reflex, and a positive femoral stretch test. On the other hand, L4 nerve root compression can lead to sensory loss in the anterior aspect of the knee, weak quadriceps, reduced knee reflex, and a positive femoral stretch test.

The management of prolapsed disc is similar to that of other musculoskeletal lower back pain. It involves analgesia, physiotherapy, and exercises. According to NICE, the first-line treatment for back pain without sciatica symptoms is NSAIDs +/- proton pump inhibitors, rather than neuropathic analgesia. If the symptoms persist after 4-6 weeks, referral for consideration of MRI is appropriate. Understanding the features of prolapsed disc can help in the diagnosis and management of this condition.

When a patient presents with back pain in the thoracic area, it is considered a red flag and requires further investigation to rule out potential serious underlying causes such as skeletal disorders, degenerative disc disease, vertebral fractures, vascular malformations, or metastasis. Additionally, if the patient exhibits fear-avoidance behavior and reduced activity, it may indicate psychosocial factors that could lead to chronic back pain. Patients under 20 or over 50 years old, those with a history of trauma, and those whose pain is worse at night are also considered red flags.

Lower back pain is a common issue that is often caused by muscular strain. However, it is important to be aware of potential underlying causes that may require specific treatment. Certain red flags should be considered, such as age under 20 or over 50, a history of cancer, night pain, trauma, or systemic illness. There are also specific causes of lower back pain that should be kept in mind. Facet joint pain may be acute or chronic, worse in the morning and on standing, and typically worsens with back extension. Spinal stenosis may cause leg pain, numbness, and weakness that is worse on walking and relieved by sitting or leaning forward. Ankylosing spondylitis is more common in young men and causes stiffness that is worse in the morning and improves with activity. Peripheral arterial disease may cause pain on walking and weak foot pulses. It is important to consider these potential causes and seek appropriate diagnosis and treatment.

Proper pain management is crucial in cases of rib fractures to ensure that breathing is not hindered by discomfort. Inadequate ventilation due to pain can increase the risk of chest infections. To prevent this, patients may benefit from chest physiotherapy and breathing exercises, along with appropriate pain relief. CPAP may be used at night to keep the airway open in patients with obstructive sleep apnoea. While prophylactic antibiotics have been shown to reduce the incidence of empyema and pneumonia in some studies of chest trauma, their routine use is controversial due to the risk of antibiotic resistance. High flow oxygen is not recommended in the absence of hypoxaemia as it does not improve the patient’s ability to take deep breaths and cough effectively.

A rib fracture is a break in any of the bony segments of a rib. It is commonly caused by blunt trauma to the chest wall, but can also be due to underlying diseases that weaken the bone structure of the ribs. Rib fractures can occur singly or in multiple places along the length of a rib and may be associated with soft tissue injuries to the surrounding muscles or the underlying lung. Risk factors include chest injuries in major trauma, osteoporosis, steroid use, chronic obstructive pulmonary disease, and cancer metastases.

The most common symptom of a rib fracture is severe, sharp chest wall pain, which is often more severe with deep breaths or coughing. Chest wall tenderness over the site of the fractures and visible bruising of the skin may also be present. Auscultation of the chest may reveal crackles or reduced breath sounds if there is an underlying lung injury. In some cases, pain and underlying lung injury can result in a reduction in ventilation, causing a drop in oxygen saturation. Pneumothorax, a serious complication of a rib fracture, can present with reduced chest expansion, reduced breath sounds, and hyper-resonant percussion on the affected side. Flail chest, a consequence of multiple rib fractures, can impair ventilation of the lung on the side of injury and may require treatment with invasive ventilation and surgical fixation to prevent complications.

Diagnostic tests for rib fractures include a CT scan of the chest, which shows the fractures in 3D as well as the associated soft tissue injuries. Chest x-rays may provide suboptimal views and do not provide any information about the surrounding soft tissue injury. In cases of pathological fractures secondary to tumour metastases, a CT scan to look for a primary (if not already identified) is also required. Management of rib fractures involves conservative treatment with good analgesia to ensure breathing is not affected by pain. Inadequate ventilation may predispose to chest infections. Nerve blocks can be considered if the pain is not controlled by normal analgesia. Surgical fixation can be considered to manage pain if this is still an issue and the fractures have failed to heal following 12 weeks of conservative management. Flail chest segments are the only form of rib fractures that should be urgently discussed with cardiothoracic surgery as they can impair ventilation and result in significant lung trauma. Lung complications such as pneumothorax or haemothorax should be managed as necessary.

Paediatric Fractures and Pathological Conditions

Paediatric fractures can be classified into different types based on the injury pattern. Complete fractures occur when both sides of the cortex are breached, while greenstick fractures only have a unilateral cortical breach. Buckle or torus fractures result in incomplete cortical disruption, leading to a periosteal haematoma. Growth plate fractures are also common in paediatric practice and are classified according to the Salter-Harris system. Injuries of Types III, IV, and V usually require surgery and may be associated with disruption to growth.

Non-accidental injury is a concern in paediatric fractures, especially when there is a delay in presentation, lack of concordance between proposed and actual mechanism of injury, multiple injuries, injuries at sites not commonly exposed to trauma, or when children are on the at-risk register. Pathological fractures may also occur due to genetic conditions such as osteogenesis imperfecta, which is characterized by defective osteoid formation and failure of collagen maturation in all connective tissues. Osteopetrosis is another pathological condition where bones become harder and more dense, and radiology reveals a lack of differentiation between the cortex and the medulla, described as marble bone.

Overall, paediatric fractures and pathological conditions require careful evaluation and management to ensure optimal outcomes for the child.

Ankylosing spondylitis (AS) patients can often find relief from their symptoms through the use of nonsteroidal anti-inflammatory drugs (NSAIDs) alone, according to the most recent guidelines from the European League Against Rheumatism (EULAR). In fact, continuous NSAID therapy is recommended for those with active and persistent symptoms, as it has been shown to slow the progression of the disease. While systemic glucocorticoids are not effective for managing AS, intra-articular steroid injections may be helpful for peripheral joint or enthesitis issues. Of traditional disease-modifying antirheumatic drugs (DMARDs), only sulphasalazine has been found to be effective for peripheral joint involvement, but it does not work for those with axial joint involvement. For those with insufficiently controlled symptoms, TNF-alpha inhibitors such as etanercept, infliximab, or adalimumab are recommended, without significant difference in efficacy between the three.

Investigating and Managing Ankylosing Spondylitis

Ankylosing spondylitis is a type of spondyloarthropathy that is associated with HLA-B27. It is more commonly seen in males aged 20-30 years old. Inflammatory markers such as ESR and CRP are usually elevated, but normal levels do not necessarily rule out ankylosing spondylitis. HLA-B27 is not a reliable diagnostic tool as it can also be positive in normal individuals. The most effective way to diagnose ankylosing spondylitis is through a plain x-ray of the sacroiliac joints. However, if the x-ray is negative but suspicion for AS remains high, an MRI can be obtained to confirm the diagnosis.

Management of ankylosing spondylitis involves regular exercise, such as swimming, and the use of NSAIDs as the first-line treatment. Physiotherapy can also be helpful. Disease-modifying drugs used for rheumatoid arthritis, such as sulphasalazine, are only useful if there is peripheral joint involvement. Anti-TNF therapy, such as etanercept and adalimumab, should be given to patients with persistently high disease activity despite conventional treatments, according to the 2010 EULAR guidelines. Ongoing research is being conducted to determine whether anti-TNF therapies should be used earlier in the course of the disease. Spirometry may show a restrictive defect due to a combination of pulmonary fibrosis, kyphosis, and ankylosis of the costovertebral joints.

Temporal arthritis frequently manifests in individuals with PMR.

Temporal arthritis, also known as giant cell arthritis, is a condition that affects medium and large-sized arteries and is of unknown cause. It typically occurs in individuals over the age of 50, with the highest incidence in those in their 70s. Early recognition and treatment are crucial to minimize the risk of complications, such as permanent loss of vision. Therefore, when temporal arthritis is suspected, urgent referral for assessment by a specialist and prompt treatment with high-dose prednisolone is necessary.

Temporal arthritis often overlaps with polymyalgia rheumatica, with around 50% of patients exhibiting features of both conditions. Symptoms of temporal arthritis include headache, jaw claudication, and tender, palpable temporal artery. Vision testing is a key investigation in all patients, as anterior ischemic optic neuropathy is the most common ocular complication. This results from occlusion of the posterior ciliary artery, leading to ischemia of the optic nerve head. Fundoscopy typically shows a swollen pale disc and blurred margins. Other symptoms may include aching, morning stiffness in proximal limb muscles, lethargy, depression, low-grade fever, anorexia, and night sweats.

Investigations for temporal arthritis include raised inflammatory markers, such as an ESR greater than 50 mm/hr and elevated CRP. A temporal artery biopsy may also be performed, and skip lesions may be present. Treatment for temporal arthritis involves urgent high-dose glucocorticoids, which should be given as soon as the diagnosis is suspected and before the temporal artery biopsy. If there is no visual loss, high-dose prednisolone is used. If there is evolving visual loss, IV methylprednisolone is usually given prior to starting high-dose prednisolone. Urgent ophthalmology review is necessary, as visual damage is often irreversible. Other treatments may include bone protection with bisphosphonates and low-dose aspirin.

When a patient with Dupuytren’s contracture is unable to straighten their metacarpophalangeal joints and place their hand flat on a table, surgical treatment should be considered. This condition occurs when the palmar fascia becomes stiff and fibroses, causing the affected fingers to contract, typically the ring and little finger of the right hand.

The severity of the condition will determine the appropriate management approach. In cases where the condition is severe and impacting the patient’s quality of life, referral to a hand specialist for secondary intervention is recommended. This may involve either surgical intervention or injectable enzyme therapy, which should only be initiated by a specialist.

For minor cases where the condition is not significantly affecting the patient’s quality of life, primary care management may be appropriate. This will involve reassurance that the condition may improve over time, regular reviews, and advice on when to return for referral if necessary.

It is important to note that corticosteroid injections are not effective in treating Dupuytren’s contracture. Additionally, as this is not an acute problem, patients should not be advised to attend the emergency department.

Understanding Dupuytren’s Contracture

Dupuytren’s contracture is a condition that affects about 5% of the population. It is more common in older men and those with a family history of the condition. The causes of Dupuytren’s contracture include manual labor, phenytoin treatment, alcoholic liver disease, diabetes mellitus, and trauma to the hand.

The condition typically affects the ring finger and little finger, causing them to become bent and difficult to straighten. In severe cases, the hand may not be able to be placed flat on a table.

Surgical treatment may be necessary when the metacarpophalangeal joints cannot be straightened.

The presence of the anti-Jo-1 antibody suggests that the patient is likely suffering from dermatomyositis, a condition characterized by muscle weakness in the proximal areas and a blue-purple rash on the face, upper eyelids, and trunk. The papules on the small joints of the hands, known as Gottron papules, are a telltale sign of this condition. While anti-CCP is often positive in rheumatoid arthritis, which causes pain and stiffness in the small joints of the hands and feet, anti-La and anti-Ro are commonly positive in Sjogren’s syndrome, which is characterized by dry mouth and eyes and swelling of the parotid gland.

Dermatomyositis is a condition that causes inflammation and muscle weakness, as well as distinct skin lesions. It can occur on its own or be associated with other connective tissue disorders or underlying cancers, particularly ovarian, breast, and lung cancer. Screening for cancer is often done after a diagnosis of dermatomyositis. Polymyositis is a variant of the disease that does not have prominent skin manifestations.

The skin features of dermatomyositis include a photosensitive macular rash on the back and shoulders, a heliotrope rash around the eyes, roughened red papules on the fingers’ extensor surfaces (known as Gottron’s papules), extremely dry and scaly hands with linear cracks on the fingers’ palmar and lateral aspects (known as mechanic’s hands), and nail fold capillary dilation. Other symptoms may include proximal muscle weakness with tenderness, Raynaud’s phenomenon, respiratory muscle weakness, interstitial lung disease (such as fibrosing alveolitis or organizing pneumonia), dysphagia, and dysphonia.

Investigations for dermatomyositis typically involve testing for ANA antibodies, which are positive in around 80% of patients. Approximately 30% of patients have antibodies to aminoacyl-tRNA synthetases, including antibodies against histidine-tRNA ligase (also called Jo-1), antibodies to signal recognition particle (SRP), and anti-Mi-2 antibodies.

Cauda equina syndrome typically manifests as lower back pain, sciatica, and decreased sensation in the perianal area. As the condition progresses, urinary incontinence may develop, which is a concerning late sign associated with irreversible damage. While a positive sciatic stretch test indicates nerve irritation or compression, it does not necessarily indicate spinal cord compression. Reduced perianal sensation is also a red flag, but it typically appears earlier than urinary incontinence. Although tingling in one leg may be caused by sciatic nerve irritation, it is not a specific sign of cauda equina syndrome, particularly if it is unilateral. While assessing anal tone is important, studies have shown that it has low sensitivity and specificity for detecting cauda equina syndrome.

Cauda equina syndrome (CES) is a rare but serious condition that occurs when the nerve roots in the lower back are compressed. It is crucial to consider CES in patients who present with new or worsening lower back pain, as a late diagnosis can result in permanent nerve damage and long-term leg weakness and urinary/bowel incontinence. The most common cause of CES is a central disc prolapse, typically at L4/5 or L5/S1, but it can also be caused by tumors, infections, trauma, or hematomas. CES can present in various ways, and there is no single symptom or sign that can diagnose or exclude it. Possible features include low back pain, bilateral sciatica, reduced sensation in the perianal area, decreased anal tone, and urinary dysfunction. Urgent MRI is necessary for diagnosis, and surgical decompression is the recommended management.

The correct diagnosis for the patient’s condition is Paget’s disease of the bone, which commonly affects the skull, spine/pelvis, and long bones of the lower extremities. This is evidenced by the patient’s distal 2/3 femur fracture with osteolytic lesions and elevated ALP levels. Myeloma, osteomalacia, and osteoporosis are incorrect diagnoses as they do not match the patient’s symptoms and blood test results.

Understanding Paget’s Disease of the Bone

Paget’s disease of the bone is a condition characterized by increased and uncontrolled bone turnover. It is believed to be caused by excessive osteoclastic resorption followed by increased osteoblastic activity. Although it is a common condition, affecting 5% of the UK population, only 1 in 20 patients experience symptoms. The most commonly affected areas are the skull, spine/pelvis, and long bones of the lower extremities. Predisposing factors include increasing age, male sex, northern latitude, and family history.

Symptoms of Paget’s disease include bone pain, particularly in the pelvis, lumbar spine, and femur. The stereotypical presentation is an older male with bone pain and an isolated raised alkaline phosphatase (ALP). Classical, untreated features include bowing of the tibia and bossing of the skull. Diagnosis is made through blood tests, which show raised ALP, and x-rays, which reveal osteolysis in early disease and mixed lytic/sclerotic lesions later.

Treatment is indicated for patients experiencing bone pain, skull or long bone deformity, fracture, or periarticular Paget’s. Bisphosphonates, either oral risedronate or IV zoledronate, are the preferred treatment. Calcitonin is less commonly used now. Complications of Paget’s disease include deafness, bone sarcoma (1% if affected for > 10 years), fractures, skull thickening, and high-output cardiac failure.

Overall, understanding Paget’s disease of the bone is important for early diagnosis and management of symptoms and complications.

Exercise is typically beneficial for inflammatory back pain, such as that seen in ankylosing spondylitis. The patient’s symptoms, including morning stiffness and improvement with exercise, suggest an inflammatory cause, which is supported by the significantly elevated ESR. While there are several possible diagnoses, including seropositive and seronegative spondyloarthropathies, the most likely explanation is ankylosing spondylitis. Psoriatic arthritis is an incorrect answer, as the patient’s rash is more consistent with dermatitis than psoriasis. Osteoarthritis is also unlikely given the patient’s age and clinical history, while reactive arthritis is less likely due to the duration of symptoms and lack of urethritis or conjunctivitis.

Ankylosing spondylitis is a type of spondyloarthropathy that is associated with HLA-B27. It is more commonly seen in young males, with a sex ratio of 3:1, and typically presents with lower back pain and stiffness that develops gradually. The stiffness is usually worse in the morning and improves with exercise, while pain at night may improve upon getting up. Clinical examination may reveal reduced lateral and forward flexion, as well as reduced chest expansion. Other features associated with ankylosing spondylitis include apical fibrosis, anterior uveitis, aortic regurgitation, Achilles tendonitis, AV node block, amyloidosis, cauda equina syndrome, and peripheral arthritis (more common in females).

AS, also known as ankylosing spondylitis, is a type of arthritis that primarily affects the spine. It causes inflammation and stiffness in the joints between the vertebrae, leading to fusion of the spine over time. AS can also affect other joints, such as the hips, shoulders, and knees, and can cause fatigue and eye inflammation. It is a chronic condition that typically develops in early adulthood and is more common in men than women. There is no cure for AS, but treatment options such as medication, exercise, and physical therapy can help manage symptoms and improve quality of life.

Lumbar spinal stenosis is a condition where the central canal in the lower back is narrowed due to degenerative changes, such as a tumor or disk prolapse. Patients may experience back pain, neuropathic pain, and symptoms similar to claudication. However, one distinguishing factor is that the pain is positional, with sitting being more comfortable than standing, and walking uphill being easier than downhill. Degenerative disease is the most common cause, starting with changes in the intervertebral disk that lead to disk bulging and collapse. This puts stress on the facet joints, causing cartilage degeneration, hypertrophy, and osteophyte formation, which narrows the spinal canal and compresses the nerve roots of the cauda equina. MRI scanning is the best way to diagnose lumbar spinal stenosis, and treatment may involve a laminectomy.

Overall, lumbar spinal stenosis is a condition that affects the lower back and can cause a range of symptoms, including pain and discomfort. It is often caused by degenerative changes in the intervertebral disk, which can lead to narrowing of the spinal canal and compression of the nerve roots. Diagnosis is typically done through MRI scanning, and treatment may involve a laminectomy. It is important to note that the pain associated with lumbar spinal stenosis is positional, with sitting being more comfortable than standing, and walking uphill being easier than downhill.

Understanding Cubital Tunnel Syndrome

Cubital tunnel syndrome is a condition that occurs when the ulnar nerve is compressed as it passes through the cubital tunnel. This can cause a range of symptoms, including tingling and numbness in the fourth and fifth fingers, which may start off intermittent but eventually become constant. Over time, patients may also experience weakness and muscle wasting. Pain is often worse when leaning on the affected elbow, and there may be a history of osteoarthritis or prior trauma to the area.

Diagnosis of cubital tunnel syndrome is usually made based on clinical features, although nerve conduction studies may be used in selected cases. Management of the condition typically involves avoiding aggravating activities, undergoing physiotherapy, and receiving steroid injections. In cases where these measures are not effective, surgery may be necessary. By understanding the symptoms and treatment options for cubital tunnel syndrome, patients can take steps to manage their condition and improve their quality of life.

Septic arthritis is most frequently observed in the knees of adults.

The patient is exhibiting symptoms of septic arthritis, such as a painful, warm, and red joint, as well as chills and a fever. The primary cause of septic arthritis is the spread of infection from a distant site through the bloodstream. In this case, the patient’s axillary abscess is likely the source of his septic arthritis.

The correct answer is knee. Among adults, septic arthritis most commonly affects the knee joint, making it the appropriate choice in this situation.

Hip is not the correct answer. Although the hip joint is also frequently affected by septic arthritis, it is less common than the knee, making it an incorrect option for this patient.

Ankles, shoulders, and elbows are also incorrect answers. While these joints can be affected by septic arthritis, they are less commonly affected than the knee, making them inappropriate choices for this patient.

Septic Arthritis in Adults: Causes, Symptoms, and Treatment

Septic arthritis is a condition that occurs when bacteria infect a joint, leading to inflammation and pain. The most common organism that causes septic arthritis in adults is Staphylococcus aureus, but in young adults who are sexually active, Neisseria gonorrhoeae is the most common organism. The infection usually spreads through the bloodstream from a distant bacterial infection, such as an abscess. The knee is the most common location for septic arthritis in adults. Symptoms include an acute, swollen joint, restricted movement, warmth to the touch, and fever.

To diagnose septic arthritis, synovial fluid sampling is necessary and should be done before administering antibiotics if necessary. Blood cultures may also be taken to identify the cause of the infection. Joint imaging may also be used to confirm the diagnosis.

Treatment for septic arthritis involves intravenous antibiotics that cover Gram-positive cocci. Flucloxacillin or clindamycin is recommended if the patient is allergic to penicillin. Antibiotic treatment is typically given for several weeks, and patients are usually switched to oral antibiotics after two weeks. Needle aspiration may be used to decompress the joint, and arthroscopic lavage may be required in some cases.

To prevent pathological fractures in bone metastases, bisphosphonates and denosumab are viable options. However, if the patient’s eGFR is less than 30, denosumab is the preferred choice. Alendronic acid should be avoided due to the patient’s history of severe reflux during previous use. Denosumab is a novel treatment for osteoporosis that inhibits the development of osteoclasts by blocking RANKL. It is administered via subcutaneous injection and is also effective in preventing skeletal-related events in adults with bone metastases from solid tumors. Cinacalcet is not indicated for the management of osteoporosis or pathological fractures, but rather for hyperparathyroidism and hypercalcemia in parathyroid carcinoma. Hormone-replacement therapy (HRT) is not recommended for the treatment of osteoporosis in older postmenopausal women due to its unfavorable risk-benefit ratio.

Denosumab: A New Treatment for Osteoporosis

Denosumab is a human monoclonal antibody that inhibits the development of osteoclasts, which are responsible for breaking down bone tissue. It is administered as a subcutaneous injection every six months at a dose of 60mg. A larger dose of 120mg may be given every four weeks to prevent skeletal-related events in adults with bone metastases from solid tumors.

When it comes to managing osteoporosis, oral bisphosphonates are still the first-line treatment, with alendronate being the preferred option. If alendronate is not tolerated, an alternative bisphosphonate such as risedronate or etidronate may be used. Next-line medications are only started if certain T score and other risk factor criteria are met. Raloxifene and strontium ranelate were previously recommended as next-line drugs, but due to safety concerns regarding strontium ranelate, denosumab is becoming increasingly popular.

Denosumab is generally well-tolerated, with dyspnea and diarrhea being the most common side effects. However, doctors should be aware of the potential for atypical femoral fractures in patients taking denosumab and should look out for patients complaining of unusual thigh, hip, or groin pain.

Overall, denosumab is a promising new treatment for osteoporosis that may be particularly useful for patients who cannot tolerate oral bisphosphonates or who have other risk factors that make them unsuitable for these medications.

Sulfasalazine: A DMARD for Inflammatory Arthritis and Bowel Disease

Sulfasalazine is a type of disease modifying anti-rheumatic drug (DMARD) that is commonly used to manage inflammatory arthritis, particularly rheumatoid arthritis, as well as inflammatory bowel disease. This medication is a prodrug for 5-ASA, which works by reducing neutrophil chemotaxis and suppressing the proliferation of lymphocytes and pro-inflammatory cytokines.

However, caution should be exercised when using sulfasalazine in patients with G6PD deficiency or those who are allergic to aspirin or sulphonamides due to the risk of cross-sensitivity. Adverse effects of sulfasalazine may include oligospermia, Stevens-Johnson syndrome, pneumonitis/lung fibrosis, myelosuppression, Heinz body anaemia, megaloblastic anaemia, and the potential to color tears and stain contact lenses.

Despite these potential side effects, sulfasalazine is considered safe to use during pregnancy and breastfeeding, making it a viable option for women who require treatment for inflammatory arthritis or bowel disease. Overall, sulfasalazine is an effective DMARD that can help manage the symptoms of these conditions and improve patients’ quality of life.

Avascular necrosis is strongly associated with prior chemotherapy treatment. Although initial x-rays may appear normal in patients with this condition, it is unlikely that they would not reveal any metastatic deposits that could cause pain.

Understanding Avascular Necrosis of the Hip

Avascular necrosis of the hip is a condition where bone tissue dies due to a loss of blood supply, leading to bone destruction and loss of joint function. This condition typically affects the epiphysis of long bones, such as the femur. There are several causes of avascular necrosis, including long-term steroid use, chemotherapy, alcohol excess, and trauma.

Initially, avascular necrosis may not present with any symptoms, but as the condition progresses, pain in the affected joint may occur. Plain x-ray findings may be normal in the early stages, but osteopenia and microfractures may be seen. As the condition worsens, collapse of the articular surface may result in the crescent sign.

MRI is the preferred investigation for avascular necrosis as it is more sensitive than radionuclide bone scanning. In severe cases, joint replacement may be necessary to manage the condition. Understanding the causes, features, and management of avascular necrosis of the hip is crucial for early detection and effective treatment.

Sulfasalazine may cause a reaction in patients who are allergic to aspirin.

Sulfasalazine: A DMARD for Inflammatory Arthritis and Bowel Disease

Sulfasalazine is a type of disease modifying anti-rheumatic drug (DMARD) that is commonly used to manage inflammatory arthritis, particularly rheumatoid arthritis, as well as inflammatory bowel disease. This medication is a prodrug for 5-ASA, which works by reducing neutrophil chemotaxis and suppressing the proliferation of lymphocytes and pro-inflammatory cytokines.

However, caution should be exercised when using sulfasalazine in patients with G6PD deficiency or those who are allergic to aspirin or sulphonamides due to the risk of cross-sensitivity. Adverse effects of sulfasalazine may include oligospermia, Stevens-Johnson syndrome, pneumonitis/lung fibrosis, myelosuppression, Heinz body anaemia, megaloblastic anaemia, and the potential to color tears and stain contact lenses.

Despite these potential side effects, sulfasalazine is considered safe to use during pregnancy and breastfeeding, making it a viable option for women who require treatment for inflammatory arthritis or bowel disease. Overall, sulfasalazine is an effective DMARD that can help manage the symptoms of these conditions and improve patients’ quality of life.

After a fragility fracture in women aged 75 or older, a DEXA scan is not required to diagnose osteoporosis and start bisphosphonate treatment, with alendronate being the first-line option. The patient in the scenario has already experienced a fragility fracture and is over 75, so a DEXA scan is unnecessary as it will not alter her management. A skeletal survey is also not needed as there are no indications of bone pathology. Raloxifene is a second-line treatment for osteoporosis and not appropriate for the patient who has had a neck of femur fracture, making alendronate the initial choice.

The NICE guidelines for managing osteoporosis in postmenopausal women include offering vitamin D and calcium supplementation, with alendronate being the first-line treatment. If a patient cannot tolerate alendronate, risedronate or etidronate may be given as second-line drugs, with strontium ranelate or raloxifene as options if those cannot be taken. Treatment criteria for patients not taking alendronate are based on age, T-score, and risk factors. Bisphosphonates have been shown to reduce the risk of fractures, with alendronate and risedronate being superior to etidronate in preventing hip fractures. Other treatments include selective estrogen receptor modulators, strontium ranelate, denosumab, teriparatide, and hormone replacement therapy. Hip protectors and falls risk assessment may also be considered in management.

Ankylosing spondylitis can be identified through x-ray findings such as subchondral erosions, which are typically seen in the corners of vertebral bodies and on the iliac side of the sacroiliac joint. This is usually preceded by subchondral sclerosis, which can lead to squaring of the lumbar vertebrae and a characteristic bamboo spine appearance. It is important to note that juxta-articular osteoporosis, loss of vertebral height, and osteopenia are not typical x-ray findings for ankylosing spondylitis.

Investigating and Managing Ankylosing Spondylitis

Ankylosing spondylitis is a type of spondyloarthropathy that is associated with HLA-B27. It is more commonly seen in males aged 20-30 years old. Inflammatory markers such as ESR and CRP are usually elevated, but normal levels do not necessarily rule out ankylosing spondylitis. HLA-B27 is not a reliable diagnostic tool as it can also be positive in normal individuals. The most effective way to diagnose ankylosing spondylitis is through a plain x-ray of the sacroiliac joints. However, if the x-ray is negative but suspicion for AS remains high, an MRI can be obtained to confirm the diagnosis.

Management of ankylosing spondylitis involves regular exercise, such as swimming, and the use of NSAIDs as the first-line treatment. Physiotherapy can also be helpful. Disease-modifying drugs used for rheumatoid arthritis, such as sulphasalazine, are only useful if there is peripheral joint involvement. Anti-TNF therapy, such as etanercept and adalimumab, should be given to patients with persistently high disease activity despite conventional treatments, according to the 2010 EULAR guidelines. Ongoing research is being conducted to determine whether anti-TNF therapies should be used earlier in the course of the disease. Spirometry may show a restrictive defect due to a combination of pulmonary fibrosis, kyphosis, and ankylosis of the costovertebral joints.

Chemotherapy can lead to a higher risk of gout due to the increased production of uric acid from the breakdown of cells. However, it is not associated with an increased risk of pseudogout or rheumatoid arthritis, which are caused by different factors such as calcium pyrophosphate crystals and genetics, respectively.

Understanding the Predisposing Factors of Gout

Gout is a type of microcrystal synovitis that occurs when monosodium urate monohydrate is deposited in the synovium. This condition is caused by chronic hyperuricaemia, which is characterized by uric acid levels that exceed 0.45 mmol/l. There are two main factors that contribute to the development of hyperuricaemia: decreased excretion of uric acid and increased production of uric acid.

One of the primary causes of decreased uric acid excretion is the use of diuretics. Chronic kidney disease and lead toxicity can also lead to decreased excretion of uric acid. On the other hand, increased production of uric acid can be caused by myeloproliferative/lymphoproliferative disorders, cytotoxic drugs, and severe psoriasis. Additionally, Lesch-Nyhan syndrome, which is an x-linked recessive disorder that is only seen in boys, can also lead to increased production of uric acid.

It is important to note that aspirin in low doses is not thought to have a significant effect on plasma urate levels. Therefore, it is recommended that it should be continued if required for cardiovascular prophylaxis. Understanding the predisposing factors of gout can help individuals take preventative measures to reduce their risk of developing this painful condition.

Osteogenesis imperfecta is a collagen disorder that is identified by blue sclera, multiple fractures during childhood, dental caries, and deafness due to otosclerosis. It is often mistaken for child abuse or neglect, but the presence of blue sclera is a crucial indicator of osteogenesis imperfecta. In contrast, rickets is more likely to cause growth stunting and deformities rather than multiple fractures.

Osteogenesis imperfecta, also known as brittle bone disease, is a group of disorders that affect collagen metabolism, leading to bone fragility and fractures. The most common type of osteogenesis imperfecta is type 1, which is inherited in an autosomal dominant manner and is caused by a decrease in the synthesis of pro-alpha 1 or pro-alpha 2 collagen polypeptides. This condition typically presents in childhood and is characterized by fractures that occur following minor trauma, as well as blue sclera, dental imperfections, and deafness due to otosclerosis.

When investigating osteogenesis imperfecta, it is important to note that adjusted calcium, phosphate, parathyroid hormone, and ALP results are usually normal. This condition can have a significant impact on a person’s quality of life, as it can lead to frequent fractures and other complications. However, with proper management and support, individuals with osteogenesis imperfecta can lead fulfilling lives.

Hand osteoarthritis is characterized by involvement of the carpometacarpal and distal interphalangeal joints, as well as the presence of painless swellings known as Heberden’s nodes. Gout, pseudogout, and psoriatic arthritis are less likely diagnoses due to their acute presentation, involvement of different joints, and/or lack of a psoriasis history.

Understanding Osteoarthritis of the Hand

Osteoarthritis of the hand, also known as nodal arthritis, is a condition that occurs when the cartilage at synovial joints is lost, leading to the degeneration of underlying bone. It is more common in women, usually presenting after the age of 55, and may have a genetic component. Risk factors include previous joint trauma, obesity, hypermobility, and certain occupations. Interestingly, osteoporosis may actually reduce the risk of developing hand OA.

Symptoms of hand OA include episodic joint pain, stiffness that worsens after periods of inactivity, and the development of painless bony swellings known as Heberden’s and Bouchard’s nodes. These nodes are the result of osteophyte formation and are typically found at the distal and proximal interphalangeal joints, respectively. In severe cases, there may be reduced grip strength and deformity of the carpometacarpal joint of the thumb, resulting in fixed adduction.

Diagnosis is typically made through X-ray, which may show signs of osteophyte formation and joint space narrowing before symptoms develop. While hand OA may not significantly impact a patient’s daily function, it is important to manage symptoms through pain relief and joint protection strategies. Additionally, the presence of hand OA may increase the risk of future hip and knee OA, particularly for hip OA.

Behcet’s disease is characterized by the presence of oral ulcers, genital ulcers, and anterior uveitis. A red and painful eye with blurred vision is a common symptom of anterior uveitis. When combined with painful oral and genital ulcers, it forms the triad that is indicative of Behcet’s disease. This condition is a type of multi-system vasculitis that typically affects men in their 20s and 30s more than women. Although sexual history should always be considered as a cause for genital ulcers, it is not relevant in this case. Chancroid, HSV, Reiter’s syndrome, and primary syphilis are not associated with the triad of symptoms seen in Behcet’s disease.

Behcet’s syndrome is a complex disorder that affects multiple systems in the body. It is believed to be caused by inflammation of the arteries and veins due to an autoimmune response, although the exact cause is not yet fully understood. The condition is more common in the eastern Mediterranean, particularly in Turkey, and tends to affect young adults between the ages of 20 and 40. Men are more commonly affected than women, although this varies depending on the country. Behcet’s syndrome is associated with a positive family history in around 30% of cases and is linked to the HLA B51 antigen.

The classic symptoms of Behcet’s syndrome include oral and genital ulcers, as well as anterior uveitis. Other features of the condition may include thrombophlebitis, deep vein thrombosis, arthritis, neurological symptoms such as aseptic meningitis, gastrointestinal problems like abdominal pain, diarrhea, and colitis, and erythema nodosum. Diagnosis of Behcet’s syndrome is based on clinical findings, as there is no definitive test for the condition. A positive pathergy test, where a small pustule forms at the site of a needle prick, can be suggestive of the condition. HLA B51 is also a split antigen that is associated with Behcet’s syndrome.

A knee injury caused by twisting can lead to a tear in the meniscus, potentially accompanied by a sprain in the medial collateral ligament. The affected knee would be swollen and tender to the touch, and a positive McMurray’s’s test (painful clicking) would also be present. Patella dislocation, which can result from direct trauma to the knee, is indicated by a positive patellar apprehension test rather than a positive McMurray’s’s test. Falling onto a bent knee can cause injury to the posterior cruciate ligament, which is indicated by a positive posterior drawer test. Hyperextension knee injury, on the other hand, most commonly results in a rupture of the anterior cruciate ligament, which is indicated by a positive anterior drawer test. Repeated jumping and landing on hard surfaces can lead to patella tendinopathy or ‘jumper’s knee’, which causes anterior knee pain that worsens with exercise and jumping over a period of 2-4 weeks.

Understanding Meniscal Tear and its Symptoms

Meniscal tear is a common knee injury that usually occurs due to twisting injuries. Its symptoms include pain that worsens when the knee is straightened, a feeling that the knee may give way, tenderness along the joint line, and knee locking in cases where the tear is displaced. To diagnose a meniscal tear, doctors may perform Thessaly’s test, which involves weight-bearing at 20 degrees of knee flexion while the patient is supported by the doctor. If the patient experiences pain on twisting the knee, the test is considered positive.

When considering the potential causes of back pain in an intravenous drug user, it is important to keep psoas abscess in mind as a possible differential diagnosis. In this particular case, the patient’s symptoms suggest the presence of infective endocarditis, as indicated by the presence of blood and protein in the urine and a systolic murmur during auscultation. However, it is unlikely that this condition is responsible for the patient’s back pain.

An iliopsoas abscess is a condition where pus accumulates in the iliopsoas compartment, which includes the iliacus and psoas muscles. There are two types of iliopsoas abscesses: primary and secondary. Primary abscesses occur due to the spread of bacteria through the bloodstream, with Staphylococcus aureus being the most common cause. Secondary abscesses are caused by underlying conditions such as Crohn’s disease, diverticulitis, colorectal cancer, UTIs, GU cancers, vertebral osteomyelitis, femoral catheterization, lithotripsy, endocarditis, and intravenous drug use. Secondary abscesses have a higher mortality rate compared to primary abscesses.

The clinical features of an iliopsoas abscess include fever, back/flank pain, limp, and weight loss. During a clinical examination, the patient is positioned supine with the knee flexed and the hip mildly externally rotated. Specific tests are performed to diagnose iliopsoas inflammation, such as placing a hand proximal to the patient’s ipsilateral knee and asking the patient to lift their thigh against the hand, which causes pain due to contraction of the psoas muscle. Another test involves lying the patient on the normal side and hyperextending the affected hip, which should elicit pain as the psoas muscle is stretched.

The investigation of choice for an iliopsoas abscess is a CT scan of the abdomen. Management involves antibiotics and percutaneous drainage, which is successful in around 90% of cases. Surgery is only indicated if percutaneous drainage fails or if there is another intra-abdominal pathology that requires surgery.

Types of Bone Tumours

Bone tumours can be classified into two categories: benign and malignant. Benign tumours are non-cancerous and do not spread to other parts of the body. Osteoma is a common benign tumour that occurs on the skull and is associated with Gardner’s syndrome. Osteochondroma, on the other hand, is the most common benign bone tumour and is usually diagnosed in patients aged less than 20 years. It is characterized by a cartilage-capped bony projection on the external surface of a bone. Giant cell tumour is a tumour of multinucleated giant cells within a fibrous stroma and is most commonly seen in the epiphysis of long bones.

Malignant tumours, on the other hand, are cancerous and can spread to other parts of the body. Osteosarcoma is the most common primary malignant bone tumour and is mainly seen in children and adolescents. It occurs most frequently in the metaphyseal region of long bones prior to epiphyseal closure. Ewing’s sarcoma is a small round blue cell tumour that is also seen mainly in children and adolescents. It occurs most frequently in the pelvis and long bones and tends to cause severe pain. Chondrosarcoma is a malignant tumour of cartilage that most commonly affects the axial skeleton and is more common in middle-age. It is important to diagnose and treat bone tumours early to prevent complications and improve outcomes.

Compartment syndrome is often linked to fractures in the supracondylar region of the arm and the tibial shaft in the lower leg. Symptoms include excessive pain, especially during passive stretching, as well as swelling and paraesthesia in the affected limb. Late signs may include numbness and paralysis.

Compartment syndrome is a complication that can occur after fractures or vascular injuries. It is characterized by increased pressure within a closed anatomical space, which can lead to tissue death. Supracondylar fractures and tibial shaft injuries are the most common fractures associated with compartment syndrome. Symptoms include pain, numbness, paleness, and possible paralysis of the affected muscle group. Diagnosis is made by measuring intracompartmental pressure, with pressures over 20 mmHg being abnormal and over 40 mmHg being diagnostic. X-rays typically do not show any pathology. Treatment involves prompt and extensive fasciotomies, with careful attention to decompressing deep muscles in the lower limb. Patients may develop myoglobinuria and require aggressive IV fluids. In severe cases, debridement and amputation may be necessary, as muscle death can occur within 4-6 hours.

The symptoms indicate the possibility of antiphospholipid syndrome, which can be confirmed by a positive anti-Cardiolipin antibody test. It is crucial to keep in mind that hypercoagulable states and hyperviscosity can lead to strokes. Antiphospholipid syndrome is a type of thrombophilia disorder that causes hypercoagulation and a higher likelihood of forming clots, both arterial and venous. This increases the risk of ischaemic strokes.

Antiphospholipid syndrome is a condition that can be acquired and is characterized by a higher risk of both venous and arterial thrombosis, recurrent fetal loss, and thrombocytopenia. It can occur as a primary disorder or as a secondary condition to other diseases, with systemic lupus erythematosus being the most common. One important point to remember for exams is that antiphospholipid syndrome can cause a paradoxical increase in the APTT. This is due to an ex-vivo reaction of the lupus anticoagulant autoantibodies with phospholipids involved in the coagulation cascade. Other features of this condition include livedo reticularis, pre-eclampsia, and pulmonary hypertension.

Antiphospholipid syndrome can also be associated with other autoimmune disorders, lymphoproliferative disorders, and, rarely, phenothiazines. Management of this condition is based on EULAR guidelines. Primary thromboprophylaxis involves low-dose aspirin, while secondary thromboprophylaxis depends on the type of thromboembolic event. Initial venous thromboembolic events require lifelong warfarin with a target INR of 2-3, while recurrent venous thromboembolic events require lifelong warfarin and low-dose aspirin. Arterial thrombosis should be treated with lifelong warfarin with a target INR of 2-3.